Rituxan News
John E. Leonard, Ph.D., Former Biogen Idec Antibody Development ... - Earthtimes
With his extensive background in antibody drug development, and his first-hand experience in the development of Rituxan(R), Zevalin(R) and most recently ...
John E. Leonard, Ph.D., Former Biogen Idec Antibody Development ... - Earthtimes
With his extensive background in antibody drug development, and his first-hand experience in the development of Rituxan(R), Zevalin(R) and most recently ...
Biogen Idec prices a public offering - Boston Globe
The Cambridge company markets such drugs as Rituxan for non-Hodgkins lymphoma and rheumatoid arthritis and Avonex, a multiple sclerosis drug; with another ...
Biogen Idec prices a public offering - Boston Globe
all 26 news articles
New therapy makes more kidney transplants possible - News 8 Austin
For the most highly sensitized patients, IVIG is combined with a new drug, Rituxan, which reduces treatment time from four months to one before ...
Zacks Bull and Bear of the Day Highlights: Genentech, Georgia Gulf ... - Business Wire (press release)
We are also encouraged by the recent positive data on Rituxan in multiple sclerosis (MS). Genentech is the world’s premier biotechnology company. ...
Genentech "outperform," target price raised - newratings.com
Avastin's adjuvant colon data, along with further Rituxan data in lupus and RA, are likely to act as catalysts for Genentech’s share price going forward, ...
Genentech shares rise; analysts say FDA approval for Avastin a ... - Trading Markets (press release)
"This approval was an important positive for Genentech as growth in its lead products (Avastin, Herceptin, Rituxan) has slowed," Credit Suisse analyst ...
Therapy Allows Some To Get Off Dialysis For Good - TheDenverChannel.com
For the most highly sensitized patients, IVIG is combined with a new drug, Rituxan, which reduces treatment time from four months to one before ...
Zacks Bull and Bear of the Day Highlights: Genentech, Georgia Gulf ... - Business Wire (press release)
We are also encouraged by the recent positive data on Rituxan in multiple sclerosis (MS). Genentech is the world’s premier biotechnology company. ...
Rituxan RSS Feed